diya aravind oct 8
DESCRIPTION
fTRANSCRIPT
-
S02 - LPL-GURGAON
C-1/B, CLEAR VIEW, OLD DLF
COLONY, SECTO R-14,
GURGAON-122001, HARYANA.
GURGAON
Name
A/c Status
Lab No.
Ref By :
Gender: Age:
Report Status
Reported
Received
Collected
P
10/10/2014 1:57:03PM
:
:
:
:
:
:
: Final
6 Years
6/10/2014 5:01:00PM
6/10/2014 5:10:16PM210635791 Female
AIIMS (DELHI)
Baby DIYA ARAVIND
Test Name Results Units Bio. Ref. Interval
LIVER & KIDNEY PANEL, SERUM
(Spectrophotometry, Indirect ISE)
141.00Urea 10.00 - 38.00 mg/dL
2.77Creatinine 0.30 - 0.70 mg/dL
6.37Uric Acid 2.60 - 6.00 mg/dL
22AST (SGOT)
-
S02 - LPL-GURGAON
C-1/B, CLEAR VIEW, OLD DLF
COLONY, SECTO R-14,
GURGAON-122001, HARYANA.
GURGAON
Name
A/c Status
Lab No.
Ref By :
Gender: Age:
Report Status
Reported
Received
Collected
P
10/10/2014 1:57:06PM
:
:
:
:
:
:
: Final
6 Years
6/10/2014 5:01:00PM
6/10/2014 5:10:16PM210635791 Female
AIIMS (DELHI)
Baby DIYA ARAVIND
Test Name Results Units Bio. Ref. Interval
COMPLETE BLOOD COUNT (CBC)
(Electrical Impedance & Flow)
Hemoglobin 11.00 - 14.00 g/dL8.90
Packed Cell Volume (PCV) 34.00 - 40.00 %28.30
RBC Count 4.00 - 5.20 mill/mm32.92
MCV 75.00 - 87.00 fL96.90
MCH 24.00 - 30.00 pg30.50
MCHC 31.00 - 37.00 g/dL31.40
Red Cell Distribution Width (RDW) 11.50 - 14.50 %13.90
Total Leukocyte Count (TLC) 5.00 - 15.00 thou/mm312.91
Differential Leucocyte Count (DLC)
Segmented Neutrophils %43.00
Lymphocytes %48.50
Monocytes %6.00
Eosinophils %2.20
Basophils %0.30
Absolute Leucocyte Count
1.50 - 8.00 Neutrophils thou/mm35.55
6.00 - 9.00 Lymphocytes thou/mm36.26
0.20 - 1.00 Monocytes thou/mm30.77
0.10 - 1.00 Eosinophils thou/mm30.28
0.01 - 0.10 Basophils thou/mm30.04
Platelet Count 150.00 - 490.00 thou/mm3356.0
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood
PatientReportSCSuperPanel.CBC_SC (Version: 4)
.
Page 2 of 6
-
S02 - LPL-GURGAON
C-1/B, CLEAR VIEW, OLD DLF
COLONY, SECTO R-14,
GURGAON-122001, HARYANA.
GURGAON
Name
A/c Status
Lab No.
Ref By :
Gender:Age:
Report Status
Reported
Received
Collected
P
10/10/2014 1:57:08PM
:
:
:
:
:
:
: Final
6 Years
6/10/2014 5:01:00PM
6/10/2014 5:10:16PM210635791 Female
AIIMS (DELHI)
Baby DIYA ARAVIND
Test Name Results Units Bio. Ref. Interval
CHOLESTEROL, TOTAL, SERUM
(Spectrophotometry)
284.00 mg/dL or = 240 | >or = 200 | ---------------------------------------------------------------------
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. As per NCEP guidelines, all adults above the age of 20 years should be screened for lipid status.
Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
BICARBONATE, SERUM @
(ISE)
15.00 mEq/L 22.00 - 29.00
Comments
Bicarbonate is the second largest fraction of anions in the plasma. At the physiological pH of blood, the
concentration of carbonate is 1/1000 that of bicarbonate. This test is a significant indicator of electrolyte
dispersion and anion deficit. An abnormal bicarbonate means a metabolic rather than a respiratory problem.
Increased Levels
Acute Metabolic alkalosis
Chronic Metabolic alkalosis
Decreased Levels
Acute Metabolic acidosis
Compensated Metabolic acidosis.
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)
.
Page 3 of 6
-
S02 - LPL-GURGAON
C-1/B, CLEAR VIEW, OLD DLF
COLONY, SECTO R-14,
GURGAON-122001, HARYANA.
GURGAON
Name
A/c Status
Lab No.
Ref By :
Gender:Age:
Report Status
Reported
Received
Collected
P
10/10/2014 1:57:08PM
:
:
:
:
:
:
: Final
6 Years
6/10/2014 5:01:00PM
6/10/2014 5:10:16PM210635791 Female
AIIMS (DELHI)
Baby DIYA ARAVIND
Test Name Results Units Bio. Ref. Interval
THYROID PROFILE, FREE, SERUM
(Chemiluminescent Immunoassay)
T3, Free; FT3 2.37 pg/mL 2.60 - 4.80
T4, Free; FT4 1.10 ng/dL 0.80 - 2.00
TSH, Ultrasensitive 14.396 uIU/mL 0.700 - 6.400
Note: TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has influence on the
measured serum TSH concentrations.
Clinical Use
Primary Hypothyroidism
Hyperthyroidism
Hypothalamic - Pituitary hypothyroidism
Inappropriate TSH secretion
Nonthyroidal illness
Autoimmune thyroid disease
Pregnancy associated thyroid disorders
Thyroid dysfunction in infancy and early childhood
Protein C, Functional @
(Chromogenic)
100.00 % 70.00 - 140.00
Note: 1. Heparin therapy may cause a spuriously low result
2. Functional assays measure only free Protein C
3. Test conducted on Citrated plasma
Comments
Protein C is a vitamin K dependent central protein in the Protein C pathway. Both genetic and acquired
deficiencies of Protein C increase the risk of thrombosis. In homozygous Protein C deficiency (< 1% activity),
individuals manifest neurologic and ophthalmic complications during intrauterine development and may have
DIC. Approximately 4-8% Protein C deficiency is prevalent in thrombophilic population. The estimated
thrombotic risk is 8-10 fold in patients with this deficiency. Congenital heterozygous Protein C deficiency may
predispose to development of Coumarin associated skin necrosis. In Type I Protein C deficiency, the
functional activity and antigenic levels are decreased to 50% of normal whereas in Type II deficiency the
functional level is decreased to 50% of normal but the antigen level is 100% of normal.
Decreased levels
Hereditary
Acquired due to Vitamin K deficiency,liver disease,Oral Anticoagulant therapy,Acute illness and DIC
Increased levels
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)
.
Page 4 of 6
-
S02 - LPL-GURGAON
C-1/B, CLEAR VIEW, OLD DLF
COLONY, SECTO R-14,
GURGAON-122001, HARYANA.
GURGAON
Name
A/c Status
Lab No.
Ref By :
Gender:Age:
Report Status
Reported
Received
Collected
P
10/10/2014 1:57:08PM
:
:
:
:
:
:
: Final
6 Years
6/10/2014 5:01:00PM
6/10/2014 5:10:16PM210635791 Female
AIIMS (DELHI)
Baby DIYA ARAVIND
Test Name Results Units Bio. Ref. Interval
Nephrotic syndrome, Ischaemic heart disease,pregnancy,use of oral contraceptives or hormone replacement
therapy
PROTEIN S, FUNCTIONAL @
(Electromechanical Clot Detection)
73.00 % 50.00 - 140.00
Note
1. Very high factor VIII (>250%) activity, Activated protein C resistance, Coumadin therapy & acute or
chronic inflammation may cause a spuriously low result
2. Functional assays measure only free Protein S
3. Test conducted on Citrated plasma
Comments
Both genetic and acquired deficiencies of protein S are associated with an increased risk of thrombosis. The
prevalence of protein S deficiency in thrombophilic population is 7-12%. The estimated thrombotic risk is
10-15 fold in patients with this deficiency. About 40% of Protein S is free in the plasma whereas remaining
60% is bound to C4b binding protein. Many pathological and physiological conditions can change the ratio of
free and bound Protein S. There is a characteristic decrease of Protein S during pregnancy with values
averaging 60% of normal from 10th week of gestation.
Classification of Protein S deficiency ----------------------------------------------------------------------------| TYPE OF DEFICIENCY | REMARKS ||--------------------|-------------------------------------------------------|| Type I | Decreased Protein S activity & antigen level ||--------------------|-------------------------------------------------------|| Type II | Decreased Protein S activity with normal levels of || | free & total antigen ||--------------------|-------------------------------------------------------|| Type III | Decreased Protein S activity with normal free antigen || | level & decreased total antigen level | ----------------------------------------------------------------------------
Decreased Levels
Hereditary
Acquired due to Vitamin K deficiency, liver disease, Oral Anticoagulant therapy, Acute illness,
pregnancy, use of Oral contraceptives,Estrogen therapy and Nephrotic syndrome
Dr. Divya.Singh
MD PATH
Chief of Lab
Dr. Nimmi Kansal
MD (Biochemistry)
HOD Biochem & IA
Dr. Sushrut Pownikar
DNB (Pathology)
HOD Hemat & Imm
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)
.
Page 5 of 6
-
S02 - LPL-GURGAON
C-1/B, CLEAR VIEW, OLD DLF
COLONY, SECTO R-14,
GURGAON-122001, HARYANA.
GURGAON
Name
A/c Status
Lab No.
Ref By :
Gender:Age:
Report Status
Reported
Received
Collected
P
10/10/2014 1:57:08PM
:
:
:
:
:
:
: Final
6 Years
6/10/2014 5:01:00PM
6/10/2014 5:10:16PM210635791 Female
AIIMS (DELHI)
Baby DIYA ARAVIND
Test Name Results Units Bio. Ref. Interval
-------------------------------End of report --------------------------------
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)
.
Page 6 of 6